CoChat

GSK-3 inhibition through GLP-1R allosteric activation mediates the neurogenesis promoting effect of P7C3 after cerebral ischemic/reperfusional injury in mice

Wang, Yea-Hwey, Liou, Kuo-Tong, Tsai, Keng-Chang, Liu, Hui-Kang, Yang, Li-Ming, Chern, Chang-Ming, Shen, Yuh-Chiang · 2018 · Toxicology and Applied Pharmacology
Cited by 22

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

&NA; An aminopropyl carbazole compound, P7C3, has been shown to be a potent neurogenesis promoting agent; however, its fundamental signaling action has yet to be elucidated. A cerebral ischemic/reperfusional (CI/R) injury model in mice was implemented to elucidate the neuronal protective mechanism(s) of P7C3. Treating CI/R mice using P7C3 (50–100 &mgr;g/kg, i.v.) significantly improved tracking distance and walking behavior, and reduced brain damage. Specifically, P7C3 promoted the expression of neurogenesis‐associated proteins, including doublecortin, beta tubulin III (&bgr;‐tub3), adam11 and adamts20, near the peri‐infarct cortex, accompanied by glycogen synthase kinase 3 (GSK‐3) inhibition and &bgr;‐catenin upregulation. The application of a specific inhibitor against glucagon‐like peptide 1 receptor (GLP‐1R), exendin(9‐39), revealed that the beneficial effects of P7C3 involved triggering the activation of GLP‐1R‐associated PKA/Akt signaling. P7C3 elicited the GLP‐1R‐dependent intracellular cAMP increment and the insulin secretion in cellular models. Surface plasmon resonance assay of P7C3 showed a Kd value of 0.53 &mgr;M for GLP‐1R binding, and the docking of P7C3 to the putative active site on GLP‐1R was successfully predicted by molecular modeling. Our findings indicate that P7C3 promotes the expression of neurogenesis proteins by activation of the cAMP/PKA‐dependent and Akt/GSK3‐associated &bgr;‐catenin through positive allosteric stimulation of GLP‐1R. Within the P7C3 class of neuroprotective molecules, this mechanism appears to be unique to the prototypical P7C3 molecule, as other active derivatives such as P7C2‐A20 and P7C3‐S243 they do not engage this same pathway and have been shown to work by nicotinamide phosphoribosyltransferase (NAMPT) stimulation. Graphical abstract Figure. No caption available. HighlightsP7C3 promoted neurogenesis in stroke mice with GSK‐3 inhibition/&bgr;‐catenin upregulation.Using GLP‐1R antagonist revealed P7C3 triggered PKA/Akt/GSK3‐dependent &bgr;‐catenin signaling.P7C3 showed a specific binding activity for GLP‐1R with a Kd value of 0.53 &mgr;M by SPR assay.Molecular modeling successfully predicted P7C3 can dock into the putative active site on GLP‐1R.P7C3 promoted neurogenesis in ischemic stroke mice by positive allosteric stimulation of GLP‐1R.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.taap.2018.08.023

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 22

Metadata

Authors
Wang, Y.-H., Liou, K.-T., Tsai, K.-C., Liu, H.-K., Yang, L.-M., Chern, C.-M., & Shen, Y.-C.
Venue
Toxicology and Applied Pharmacology
Publisher
Elsevier BV
Published
2018-10
Volume
357
Pages
88-105
ISSN
0041-008X (ISSN-L)
OpenAlex
W2890215758
Cited by
22
References
8
FWCI
0.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.